PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Proteomics International Laboratories Ltd (PIQ.AX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

AU000000PIQ0

Sector

Healthcare

Highlights

Market Cap

A$81.88M

EPS (TTM)

-A$0.05

Total Revenue (TTM)

A$2.66M

Gross Profit (TTM)

A$1.55M

EBITDA (TTM)

-A$2.50M

Year Range

A$0.55 - A$1.40

Target Price

A$0.50

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of A$10,000 in Proteomics International Laboratories Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-40.00%-30.00%-20.00%-10.00%0.00%10.00%20.00%SeptemberOctoberNovemberDecember2025February
-27.01%
16.26%
PIQ.AX (Proteomics International Laboratories Ltd)
Benchmark (^GSPC)

Returns By Period

Proteomics International Laboratories Ltd had a return of -20.63% year-to-date (YTD) and -37.44% in the last 12 months.


PIQ.AX

YTD

-20.63%

1M

-4.51%

6M

-27.01%

1Y

-37.44%

5Y*

14.07%

10Y*

N/A

^GSPC (Benchmark)

YTD

4.22%

1M

2.22%

6M

9.51%

1Y

22.46%

5Y*

12.74%

10Y*

11.29%

*Annualized

Monthly Returns

The table below presents the monthly returns of PIQ.AX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-19.38%-20.63%
202410.61%5.05%10.58%-5.22%-11.01%-9.28%2.27%-8.33%-17.58%6.62%-6.21%17.65%-10.61%
202315.26%-12.33%0.00%-7.81%9.60%-11.34%-4.65%6.10%27.59%-13.51%-6.77%-0.00%-5.79%
2022-17.70%25.50%-3.98%-12.45%-6.64%-5.58%-5.91%9.14%5.76%-9.41%-3.83%7.95%-21.81%
2021-13.84%94.89%-11.61%-4.24%4.87%-21.94%29.73%-8.33%-19.09%7.87%23.96%2.10%52.83%
2020-0.00%-3.70%-3.85%32.00%1.52%25.37%38.10%5.17%-14.75%-1.92%1.96%52.88%194.44%
2019-7.89%-7.14%-7.69%-6.67%0.00%25.00%-10.00%-12.70%18.18%-1.54%1.56%-16.92%-28.95%
20189.26%-8.47%-12.96%-10.64%9.52%-13.04%47.50%-18.64%-2.08%2.13%100.00%-20.83%40.74%
2017-12.00%-13.64%5.26%-10.00%-8.33%-6.06%16.13%8.33%2.56%-10.00%-0.00%50.00%8.00%
2016-0.00%1.75%-17.24%-16.67%17.50%12.77%-1.89%-7.69%-2.08%19.15%-1.79%-9.09%-12.28%
2015-2.22%-9.09%72.50%-1.45%5.88%-30.56%92.00%-20.83%-25.00%26.67%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of PIQ.AX is 20, meaning it’s performing worse than 80% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of PIQ.AX is 2020
Overall Rank
The Sharpe Ratio Rank of PIQ.AX is 2020
Sharpe Ratio Rank
The Sortino Ratio Rank of PIQ.AX is 2222
Sortino Ratio Rank
The Omega Ratio Rank of PIQ.AX is 2222
Omega Ratio Rank
The Calmar Ratio Rank of PIQ.AX is 1212
Calmar Ratio Rank
The Martin Ratio Rank of PIQ.AX is 2424
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Proteomics International Laboratories Ltd (PIQ.AX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for PIQ.AX, currently valued at -0.49, compared to the broader market-2.000.002.004.00-0.491.77
The chart of Sortino ratio for PIQ.AX, currently valued at -0.38, compared to the broader market-6.00-4.00-2.000.002.004.006.00-0.382.39
The chart of Omega ratio for PIQ.AX, currently valued at 0.95, compared to the broader market0.501.001.502.000.951.32
The chart of Calmar ratio for PIQ.AX, currently valued at -0.61, compared to the broader market0.002.004.006.00-0.612.66
The chart of Martin ratio for PIQ.AX, currently valued at -0.92, compared to the broader market0.0010.0020.0030.00-0.9210.85
PIQ.AX
^GSPC

The current Proteomics International Laboratories Ltd Sharpe ratio is -0.49. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Proteomics International Laboratories Ltd with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.49
2.06
PIQ.AX (Proteomics International Laboratories Ltd)
Benchmark (^GSPC)

Dividends

Dividend History


Proteomics International Laboratories Ltd doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-52.96%
-1.32%
PIQ.AX (Proteomics International Laboratories Ltd)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Proteomics International Laboratories Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Proteomics International Laboratories Ltd was 79.58%, occurring on May 22, 2017. Recovery took 786 trading sessions.

The current Proteomics International Laboratories Ltd drawdown is 52.96%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-79.58%Jun 10, 2015372May 22, 2017786Dec 9, 20201158
-58.15%Apr 20, 2021833Sep 18, 2024
-21.28%Apr 30, 20159May 12, 201518Jun 9, 201527
-17.16%Feb 24, 202111Mar 10, 202125Apr 16, 202136
-17.07%Dec 22, 202025Feb 1, 20216Feb 9, 202131

Volatility

Volatility Chart

The current Proteomics International Laboratories Ltd volatility is 10.64%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%SeptemberOctoberNovemberDecember2025February
10.64%
3.33%
PIQ.AX (Proteomics International Laboratories Ltd)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Proteomics International Laboratories Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Proteomics International Laboratories Ltd.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab